Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.

Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
10 01 2019
Historique:
entrez: 12 1 2019
pubmed: 12 1 2019
medline: 12 1 2019
Statut: epublish

Résumé

The original version of this Article contained an error in the spelling of a member of the PRACTICAL Consortium, Manuela Gago-Dominguez, which was incorrectly given as Manuela Gago Dominguez. This has now been corrected in both the PDF and HTML versions of the Article. Furthermore, in the original HTML version of this Article, the order of authors within the author list was incorrect. The PRACTICAL consortium was incorrectly listed after Richard S. Houlston and should have been listed after Nora Pashayan. This error has been corrected in the HTML version of the Article; the PDF version was correct at the time of publication.

Identifiants

DOI: 10.1038/s41467-018-08107-8 PMID: 30631080 PMC: PMC6328616
pubmed: 30631080
doi: 10.1038/s41467-018-08107-8
pii: 10.1038/s41467-018-08107-8
pmc: PMC6328616
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Pagination

213

Subventions

Organisme : Cancer Research UK
ID : 10119
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 10124
Pays : United Kingdom

Investigateurs

Brian E Henderson (BE)
Christopher A Haiman (CA)
Sara Benlloch (S)
Fredrick R Schumacher (FR)
Ali Amin Al Olama (AAA)
Sonja I Berndt (SI)
David V Conti (DV)
Fredrik Wiklund (F)
Stephen Chanock (S)
Victoria L Stevens (VL)
Catherine M Tangen (CM)
Jyotsna Batra (J)
Judith Clements (J)
Henrik Gronberg (H)
Johanna Schleutker (J)
Demetrius Albanes (D)
Stephanie Weinstein (S)
Alicja Wolk (A)
Catharine West (C)
Lorelei Mucci (L)
Géraldine Cancel-Tassin (G)
Stella Koutros (S)
Karina Dalsgaard Sorensen (KD)
Eli Marie Grindedal (EM)
David E Neal (DE)
Freddie C Hamdy (FC)
Jenny L Donovan (JL)
Ruth C Travis (RC)
Robert J Hamilton (RJ)
Sue Ann Ingles (SA)
Barry Rosenstein (B)
Yong-Jie Lu (YJ)
Graham G Giles (GG)
Adam S Kibel (AS)
Ana Vega (A)
Manolis Kogevinas (M)
Kathryn L Penney (KL)
Jong Y Park (JY)
Janet L Stanford (JL)
Cezary Cybulski (C)
Børge G Nordestgaard (BG)
Hermann Brenner (H)
Christiane Maier (C)
Jeri Kim (J)
Esther M John (EM)
Manuel R Teixeira (MR)
Susan L Neuhausen (SL)
Kim De Ruyck (K)
Azad Razack (A)
Lisa F Newcomb (LF)
Davor Lessel (D)
Radka Kaneva (R)
Nawaid Usmani (N)
Frank Claessens (F)
Paul A Townsend (PA)
Manuela Gago-Dominguez (M)
Monique J Roobol (MJ)
Florence Menegaux (F)
Kay-Tee Khaw (KT)
Lisa Cannon-Albright (L)
Hardev Pandha (H)
Stephen N Thibodeau (SN)

Commentaires et corrections

Type : ErratumFor

Auteurs

Molly Went (M)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.

Amit Sud (A)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
ORCID: 0000-0002-6133-0164

Asta Försti (A)

German Cancer Research Center, 69120, Heidelberg, Germany.
Center for Primary Health Care Research, Lund University, SE-205 02, Malmo, Sweden.

Britt-Marie Halvarsson (BM)

Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden.

Niels Weinhold (N)

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Department of Internal Medicine V, University of Heidelberg, 69117, Heidelberg, Germany.

Scott Kimber (S)

Division of Molecular Pathology, The Institute of Cancer Research, London, SW7 3RP, UK.

Mark van Duin (M)

Department of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands.

Gudmar Thorleifsson (G)

deCODE Genetics, Sturlugata 8, IS-101, Reykjavik, Iceland.

Amy Holroyd (A)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.

David C Johnson (DC)

Division of Molecular Pathology, The Institute of Cancer Research, London, SW7 3RP, UK.
ORCID: 0000-0003-0887-3343

Ni Li (N)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.

Giulia Orlando (G)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.

Philip J Law (PJ)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
ORCID: 0000-0001-9663-4611

Mina Ali (M)

Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden.

Bowang Chen (B)

German Cancer Research Center, 69120, Heidelberg, Germany.

Jonathan S Mitchell (JS)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.

Daniel F Gudbjartsson (DF)

deCODE Genetics, Sturlugata 8, IS-101, Reykjavik, Iceland.
School of Engineering and Natural Sciences, University of Iceland, IS-101, Reykjavik, Iceland.
ORCID: 0000-0002-5222-9857

Rowan Kuiper (R)

Department of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands.

Owen W Stephens (OW)

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.

Uta Bertsch (U)

German Cancer Research Center, 69120, Heidelberg, Germany.
National Centre of Tumor Diseases, 69120, Heidelberg, Germany.

Peter Broderick (P)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
ORCID: 0000-0002-8348-5829

Chiara Campo (C)

German Cancer Research Center, 69120, Heidelberg, Germany.

Obul R Bandapalli (OR)

German Cancer Research Center, 69120, Heidelberg, Germany.
ORCID: 0000-0002-1132-1745

Hermann Einsele (H)

University Clinic of Würzburg, 97080, Würzburg, Germany.

Walter A Gregory (WA)

Clinical Trials Research Unit, University of Leeds, Leeds, LS2 9PH, UK.

Urban Gullberg (U)

Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden.

Jens Hillengass (J)

Department of Internal Medicine V, University of Heidelberg, 69117, Heidelberg, Germany.

Per Hoffmann (P)

Institute of Human Genetics, University of Bonn, D-53127, Bonn, Germany.
Division of Medical Genetics, Department of Biomedicine, University of Basel, 4003, Basel, Switzerland.

Graham H Jackson (GH)

Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK.

Karl-Heinz Jöckel (KH)

Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, D-45147, Germany.

Ellinor Johnsson (E)

Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden.

Sigurður Y Kristinsson (SY)

Department of Hematology, Landspitali, National University Hospital of Iceland, IS-101, Reykjavik, Iceland.

Ulf-Henrik Mellqvist (UH)

Section of Hematology, Sahlgrenska University Hospital, Gothenburg, 413 45, Sweden.

Hareth Nahi (H)

Center for Hematology and Regenerative Medicine, SE-171 77, Stockholm, Sweden.

Douglas Easton (D)

Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
ORCID: 0000-0003-2444-3247

Paul Pharoah (P)

Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
ORCID: 0000-0001-8494-732X

Alison Dunning (A)

Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.

Julian Peto (J)

Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.

Federico Canzian (F)

Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
ORCID: 0000-0002-4261-4583

Anthony Swerdlow (A)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
Division of Breast Cancer Research, The Institute of Cancer Research, London, SW7 3RP, UK.

Rosalind A Eeles (RA)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK.
ORCID: 0000-0002-3698-6241

Zsofia Kote-Jarai (Z)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.

Kenneth Muir (K)

Institute of Population Health, University of Manchester, Manchester, M13 9PL, UK.
Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.
ORCID: 0000-0001-6429-988X

Nora Pashayan (N)

Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.
Department of Applied Health Research, University College London, London, WC1E 7HB, UK.
ORCID: 0000-0003-0843-2468

Jolanta Nickel (J)

Department of Internal Medicine V, University of Heidelberg, 69117, Heidelberg, Germany.

Markus M Nöthen (MM)

Institute of Human Genetics, University of Bonn, D-53127, Bonn, Germany.
Department of Genomics, Life & Brain Center, University of Bonn, D-53127, Bonn, Germany.

Thorunn Rafnar (T)

deCODE Genetics, Sturlugata 8, IS-101, Reykjavik, Iceland.

Fiona M Ross (FM)

Wessex Regional Genetics Laboratory, University of Southampton, Salisbury, SP2 8BJ, UK.

Miguel Inacio da Silva Filho (MI)

German Cancer Research Center, 69120, Heidelberg, Germany.

Hauke Thomsen (H)

German Cancer Research Center, 69120, Heidelberg, Germany.

Ingemar Turesson (I)

Hematology Clinic, Skåne University Hospital, SE-221 85, Lund, Sweden.

Annette Vangsted (A)

Department of Haematology, University Hospital of Copenhagen at Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.

Niels Frost Andersen (NF)

Department of Haematology, Aarhus University Hospital, Tage-Hansens Gade 2, DK-8000, Aarhus C, Denmark.

Anders Waage (A)

Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Box 8905, N-7491, Trondheim, Norway.

Brian A Walker (BA)

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.

Anna-Karin Wihlborg (AK)

Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden.

Annemiek Broyl (A)

Department of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands.

Faith E Davies (FE)

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.

Unnur Thorsteinsdottir (U)

deCODE Genetics, Sturlugata 8, IS-101, Reykjavik, Iceland.
Faculty of Medicine, University of Iceland, IS-101, Reykjavik, Iceland.

Christian Langer (C)

Department of Internal Medicine III, University of Ulm, D-89081, Ulm, Germany.

Markus Hansson (M)

Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden.
Hematology Clinic, Skåne University Hospital, SE-221 85, Lund, Sweden.
ORCID: 0000-0002-7715-4548

Hartmut Goldschmidt (H)

Department of Internal Medicine V, University of Heidelberg, 69117, Heidelberg, Germany.
National Centre of Tumor Diseases, 69120, Heidelberg, Germany.

Martin Kaiser (M)

Division of Molecular Pathology, The Institute of Cancer Research, London, SW7 3RP, UK.

Pieter Sonneveld (P)

Department of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands.

Kari Stefansson (K)

deCODE Genetics, Sturlugata 8, IS-101, Reykjavik, Iceland.

Gareth J Morgan (GJ)

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.

Kari Hemminki (K)

German Cancer Research Center, 69120, Heidelberg, Germany. K.Hemminki@dkfz-heidelberg.de.
Center for Primary Health Care Research, Lund University, SE-205 02, Malmo, Sweden. K.Hemminki@dkfz-heidelberg.de.

Björn Nilsson (B)

Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, Lund University, SE-221 84, Lund, Sweden. bjorn.nilsson@med.lu.se.
Broad Institute, 7 Cambridge Center, Cambridge, MA, 02142, USA. bjorn.nilsson@med.lu.se.

Richard S Houlston (RS)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK. richard.houlston@icr.ac.uk.
Division of Molecular Pathology, The Institute of Cancer Research, London, SW7 3RP, UK. richard.houlston@icr.ac.uk.
ORCID: 0000-0002-5268-0242

Classifications MeSH